Liothyronine Sodium

CAS 55-06-1 4 current records 1 historicalSmall Molecule

Who holds supplier records for Liothyronine Sodium? 4 organisations hold a current record for Liothyronine Sodium: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3) and Germany (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Liothyronine Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/liothyronine-sodium

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Liothyronine Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Liothyronine Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Liothyronine Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 3 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
AZICO BIOPHORE INDIA PRIVATE LIMITED AnakapalliIN
CEP 2017-035 - Rev 01
Liothyronine sodium
Nov 2023—
Peptido GmbH BexbachDE
R1-CEP 2006-249 - Rev 02
Liothyronine sodium
Jul 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Liothyronine Sodium are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • Germany · Inactive DMF 7110 · filed Aug 1987

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Liothyronine Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201119).

Chemical identity

IUPAC name
sodium (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate
Canonical SMILES
C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)[O-])N)I)I)O.[Na+]
InChIKey
SBXXSUDPJJJJLC-YDALLXLXSA-M
Synonyms
Basoprocin, Cynomel, Cytobin, Cytomel, Ibiothyron, Liothyronine hydrochloride, Liothyronine sodium, Liothyronine sodium salt, Liotrix (t3), L-triiodothyronine hydrochloride, L-triiodothyronine sodium salt, Lyothyronin

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
l-Triiodothyronine
Chemical structure
Triiodothyronine

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Liothyronine Sodium?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Liothyronine Sodium: AZICO BIOPHORE INDIA PVT LTD (India), PEPTIDO GMBH (Germany), Macleods Pharmaceuticals Ltd. (India) and VALARY LAB PRIVATE LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Liothyronine Sodium Drug Master Files are active?

AZICO BIOPHORE INDIA PVT LTD (DMF 30942), PEPTIDO GMBH (DMF 19467), Macleods Pharmaceuticals Ltd. (DMF 42401) and VALARY LAB PRIVATE LIMITED (DMF 38903). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Liothyronine Sodium records mean?

1 organisation has only inactive Type II DMFs for Liothyronine Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Liothyronine Sodium have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Liothyronine Sodium on the EDQM register, including AZICO BIOPHORE INDIA PRIVATE LIMITED Anakapalli (IN) and Peptido GmbH Bexbach (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Liothyronine Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Liothyronine Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.